Sign In

Agnes Bliecq

Regulatory Program Director at Genentech

Professional Background

Agnes Bliecq is a highly accomplished professional in the field of regulatory affairs, particularly within the oncology sector. Currently serving as the Program Director of Regulatory Affairs - Oncology at Genentech, Agnes has consistently demonstrated her expertise in drug development and regulatory strategies, which are vital components in bringing innovative cancer therapies to market. Her career at Genentech is marked by progressive leadership roles, showcasing her ability to manage and navigate the complexities of regulatory processes associated with oncology treatments.

Agnes began her professional journey at Genentech in various capacities, gradually working her way up from an internship in Clinical Regulatory Affairs to her current directorial role. Each position has equipped her with a nuanced understanding of drug registration and development, allowing her to contribute significantly to the advancement of the pharmaceutical landscape in oncology. Her tenure includes significant milestones, such as her responsibilities as the Associate Program Director - Oncology and the Regulatory Program Manager - Oncology, where she honed her skills in cross-functional collaboration and regulatory submission strategies. These roles have positioned her as a thought leader within the regulatory affairs community, where she continues to advocate for patient-centric approaches in drug development.

In addition to her current role at Genentech, Agnes has a solid foundation in organizational communication, having been involved in a Group Communication Rotation at Roche. This experience enriched her capabilities in navigating complex projects and collaborating with diverse teams, reinforcing her adeptness in steering communication strategies in the pharmaceutical industry.

Education and Achievements

Agnes Bliecq's academic background is richly grounded in the field of pharmacy, having studied at notable institutions in France. She completed her studies in Pharmacy at Université de Caen Normandie, where she acquired essential knowledge about pharmacology and drug development. Pursuing her passion for drug registration and development, Agnes furthered her education with a Master’s degree in International Drug Development and Registration from Université de Paris Sud 11. This advanced education provided her with international perspectives on regulatory affairs and a robust framework necessary for recognizing and addressing the challenges of drug registration on a global scale.

Agnes's education has complemented her vast experience in the industry, where she has not only contributed to her organizations but has also engaged in professional development, keeping her skills sharp and relevant amidst the evolving dynamics of the pharmaceutical arena. Her commitment to continuous learning reflects her dedication to excellence and innovation in drug development.

Achievements

Throughout her career, Agnes has achieved multiple milestones that underscore her significant contributions to the field of oncology and regulatory affairs. At Genentech, her leadership in various program management roles has led to successful regulatory submissions that have advanced novel therapies aimed at addressing the needs of cancer patients. Her ability to navigate rigorous regulatory frameworks and compliance measures has been pivotal in the success of oncology drug projects, helping to ensure that new treatments reach patients swiftly and safely.

In addition to her technical accomplishments, Agnes's strategic insight and collaborative spirit have made her a key player in interdepartmental initiatives that enhance operational efficiencies and promote transparency throughout the drug development process. Her experience at Roche further enriched her understanding of the importance of effective communication in regulatory settings, which is crucial in fostering trust and teamwork amongst multidisciplinary teams.

Agnes Bliecq is not just a leader in regulatory affairs; she is passionate about making a tangible difference at the intersection of science and patient care. Her journey through enhancing her expertise while leading impactful projects reflects her dedication to improving the lives of those affected by cancer and ensuring that they have access to innovative therapies. With a robust educational foundation and a wealth of career experience, Agnes continues to exemplify excellence in the field of oncology regulatory affairs.

Related Questions

How did Agnes Bliecq transition from her internship roles to becoming a Program Director at Genentech?
What innovative strategies has Agnes Bliecq implemented in her role as Program Director, Regulatory Affairs - Oncology?
How has Agnes Bliecq's education at Université de Paris Sud 11 influenced her approach to drug registration?
What are the biggest challenges Agnes Bliecq has faced in regulatory affairs within the oncology sector?
In what ways has Agnes Bliecq contributed to cross-functional collaboration at Genentech?
Agnes Bliecq
Add to my network

Location

South San Francisco, California, United States